2-(Iodomethyl)tetrahydro-2H-pyran, 97.0%, 250mg

{[5-(1-Benzofuran-2-yl)isoxazol-3-yl]methyl}amine hydrochloride, 95.0%, 1g

Dicyclopentadiene (stabilised with BHT), 97.0%, 500g

1-(2-Methoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 10g

8-Chloro-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione, 95.0%, 250g

Anti-GalNAc-GD1a Monoclonal Antibody (2A3D2)1vial

tert-Butyl 4-phenylpiperidine-1-carboxylate, 95.0%, 5g

5-azetidin-3-yl-3-benzyl-1,2,4-oxadiazole hydrochloride, 95.0%, 2.5g

Ethyl 2-(4-methoxyphenyl)acetate, 95.0%, 100g

5-Pyrimidineacetic acid, 98.0%, 250mg

CIS-3-AMINO-2,2-DIMETHYLCYCLOBUTANOL HCL, 95.0%, 250mg

2-Bromo-5-methoxybenzotrifluoride, 98.0%, 500g

Bis(2-methylallyl)(1,5-cyclooctadiene)ruthenium(II), 97%, 250mg